BAY85-3934
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for BAY85-3934, covering 2014-05-06 to 2019-09-20. Get the full timeline:
Most recent: Clinical Trial Update: Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934 [Phase 2]